Background: The aim of the study was to highlight the need for adequate anticoagulant therapy as well as the correlation of higher threat of stroke
Background: The aim of the study was to highlight the need for adequate anticoagulant therapy as well as the correlation of higher threat of stroke. CHA2DS2-VASc rating ( 0.05). Our outcomes also display that rivaroxaban can be more commonly recommended like a release therapy than warfarin (2 = 12.401; = 0.0001). Furthermore, a considerably higher…